[Skip to Content]
[Skip to Content Landing]
February 20, 1926


JAMA. 1926;86(8):567-568. doi:10.1001/jama.1926.02670340045022

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The Spahlinger Treatment of Tuberculosis  The Journal de Genève has published a dispatch dated London, January 16, which reads: "A foundation has just been formed in England with the object to raise the sum of £100,000 sterling necessary for acquiring the rights to use Spahlinger's treatment for the cure of tuberculosis. Mr. Roscoe Brunner, director of the firm of Brunner, Mond and Company, manufacturing chemists, who made a speech at Manchester on this subject, stated that it would be necessary to first raise £40,000 sterling for the purpose of establishing a laboratory at Geneva."This news item requires comment. Mr. Spahlinger is not a member of the medical profession, but studied law and afterward worked at the Pasteur Institute at Paris. Some years ago he took an estate in Carange, a suburb of Geneva, and there carried out his work for the cure of tuberculosis with a serum of his

First Page Preview View Large
First page PDF preview
First page PDF preview